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ABSTRACT: The cyclic dodecapeptides wewakazole and wewakazole B have been synthesized by a 
divergent strategy via a common tris-proline containing oxazole octapeptide and two separate bis-
oxazole containing tetrapeptide units, followed by peptide coupling and macrocyclization. The three ox-
azole amino acid fragments are readily accessible by rhodium(II)-catalysed amide N–H insertion of di-
azocarbonyl compounds, or by the cycloaddition of rhodium carbenoids with nitriles.
Wewakazole 1 was isolated from the cyanobacterium Lyngbya majuscula off the coast of Papua New 
Guinea in 2003, and assigned a modified cyclododecapeptide structure incorporating three prolines, and 
in which one threonine and two serine residues had been cyclized to form oxazoles.1 Although no bio-
logical activity was reported, subsequent studies showed that it was active against non-small cell lung 
cancer H-460 cells.2 Thirteen years later, the structurally related wewakazole B 2 was reported from a 
different genus of cyanobacteria, Moorea producens, in the Red Sea.3 Wewakazole B was of particular 
interest, given its reported anticancer activity (IC50 0.58 µM against MCF7 breast cancer cells),3 and the 
scarcity of material for further biological evaluation. Although two total syntheses of wewakazole B 
have recently been reported,4,5its mode of action remains unknown. Given our previous work in the syn-
thesis of post-translationally modified peptides, and particularly those containing azoles,6-10 these two 
structures caught our attention as attractive targets for total synthesis.  
The two wewakazole structures differ only by the presence or absence of a methyl group on one oxazole 
and the identity of two of the peptide residues: the 5-unsubstituted oxazole, phenylalanine and valine 
present in wewakazole are replaced with a 5-methyloxazole, alanine and phenylalanine in wewakazole 
B. As all these variations are found within one portion of the structures, a divergent strategy for the syn-
thesis of the two compounds presented itself, whereby the common octapeptide 3 could be synthesized 
and coupled to the two bis-oxazole containing tetrapeptide units 4 and 5. An additional advantage of this 
approach is that macrocyclization can be carried out by amide coupling of the N-terminal to a C-
terminal glycine, reducing the steric bulk around the reactive center and minimizing the risk of epimeri-
zation in what will inevitably be a highly dilute, and hence slow, macrocyclization step. We have previ-
ously reported the use of rhodium(II)-catalyzed amide N–H insertion of diazocarbonyl compounds for 
 the synthesis of 5-substituted oxazoles,11,12 as well as the cycloaddition of metallocarbenoids with ni-
triles for the synthesis of 5-unsubstituted oxazoles.13,14 Our retrosynthetic plan employs both these reac-
tions, allowing the wewakazoles to be retrosynthesized to their component L-amino acids, and two di-
azocarbonyl compounds 6 and 7 (Scheme 1). A protecting group strategy using methyl and ethyl C-
terminal esters and N-terminal Boc groups was chosen, as the required intermediates ought to be other-
wise inert to the deprotection conditions for these groups. 
 
 
Figure 1. Structures of the cyclododecapeptides wewakazole and wewakazole B highlighting structural 
differences. 
 
 Scheme 1. Retrosynthesis of the wewakazoles. 
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 The synthesis began with the construction of the common octapeptide fragment 3. Coupling of Boc-
alanine to proline methyl ester, and of Boc-proline to glycine methyl ester, both proceeded without dif-
ficulty using N,N,N′,N′-tetramethyl-O-(1H-benzotriazol-1-yl)uronium hexafluorophosphate (HBTU) and 
N,N-diisopropylethylamine (DIPEA) to give dipeptides 8 and 10. Upon removal of both proline protect-
ing groups, the coupling of these acid 9 and amine 11 fragments proved more difficult; HBTU gave very 
poor results, but the use of N-(3-dimethylaminopropyl)-N′-ethylcarbodiimide hydrochloride (EDCI) and 
1-hydroxybenzotriazole (HOBt) gave the desired tetrapeptide 12 in 80% yield (Scheme 2). Deprotection 
of the Boc-group in tetrapeptide 12 was only carried out immediately prior to its further reaction, as the 
hydrochloride salt 13 was hygroscopic. The presence of a Pro-Pro linkage generally caused rotameric 
behavior to be observed in the NMR spectra of these intermediates, but this could be minimized by the 
use of deuterated DMSO as the solvent. The use of variable temperature NMR further reduced the oc-
currence of rotamers, although this was not performed routinely on all the rotameric intermediates.  
 
Scheme 2. Synthesis of first tetrapeptide fragment. 
 
 
Concurrently, Boc-isoleucinamide was dehydrated with diethyl chlorophosphate to give the nitrile 14. 
Slow addition of diazo compound 6 to a solution of the nitrile and Rh2(pfm)4 in chloroform at reflux 
gave only a 30% yield of the oxazole, but with recovery of 65% of the nitrile giving an 86% yield based 
on recovered starting material. Attempts to increase the conversion beyond this led to much lower re-
covery of material. The oxazole 15 was treated with HCl in dioxane to give the hydrochloride salt 16. 
Finally, Boc-phenylalanine was coupled to proline methyl ester with HBTU to give dipeptide 17, and 
the ester was hydrolyzed to give the carboxylic acid 18. Coupling of amine 16 and acid 18 gave the 
tetrapeptide 19, hydrolysis of which gave the carboxylic acid 20 (Scheme 3).  
The coupling of the two tetrapeptide units 13 and 20 proved challenging; EDCI gave only 30% yield, 
while reagents such as 1-[bis(dimethylamino)methylene]-1H-1,2,3-triazolo[4,5-b] pyridinium 3-oxide 
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 hexafluorophosphate (HATU), HBTU, benzotriazol-1-yl-oxytripyrrolidinophosphonium hexafluoro-
phosphate (PyBOP) and 2,4,6-tripropyl-1,3,5,2,4,6-trioxatriphosphorinane-2,4,6-trioxide (T3P) offered 
little improvement. Eventually, it was found that the use of 4-(4,6-dimethoxy-1,3,5-triazin-2-yl)-4-
methylmorpholinium chloride (DMTMM)15 in THF gave a satisfactory 77% yield, despite the poor sol-
ubility of the coupling agent in that solvent. This reaction could be carried out on gram scale in 67% 
yield, permitting access to large quantities of the common octapeptide fragment 3.  
Attention then turned to the synthesis of the two bis-oxazole fragments 4 and 5. The wewakazole A 
fragment 4 was synthe-sized via the phenylalanine-derived nitrile 22, which underwent cycloaddition 
with diazo compound 6 to give oxazole 23 in 38% yield, again with significant recovery of the nitrile 
(43%), followed by Boc deprotection. A solution of Boc-valinamide and Rh2(OAc)4 in refluxing chloro-
form was subjected to dropwise addition of diazo compound 7, giving the intermediate N-H insertion 
product in moderate yield.6 Cyclodehydration under Wipf’s conditions16 using triphenylphosphine, io-
dine and triethylamine gave the oxazole 25 in good yield, and treatment with lithium hydroxide gave the 
carboxylic acid 26. Coupling amine 24 with acid 26 using HATU gave the desired bis-oxazole 27 in ex-
cellent yield, followed by hydrolysis to yield the wewakazole A fragment 4.  
 
Scheme 3. Synthesis of second tetrapeptide fragment. 
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 Scheme 4. Synthesis of the common octapeptide 3.  
 
 
Scheme 5. Synthesis of bis-oxazole fragment of wewakazole. 
 
 
Towards the synthesis of wewakazole B, Boc-alaninamide and Boc-phenylalaninamide were each 
subjected to the N-H insertion-cyclodehydration sequence to give oxazoles 28 and 30 respectively. Boc-
deprotection of 28 and ester deprotection of 30, followed by coupling of the resulting amine 29 and acid 
31 using HATU gave the bis-oxazole 32.  Final hydrolysis gave the wewakazole B fragment 5 (Scheme 
6). 
With all the required fragments in hand, all that remained was to couple them together to synthesize 
both natural products. The bis-oxazole 4 was coupled to the octapeptide 3 using DMTMM to give the 
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 cyclization precursor 33 in 69% yield. The termini were deprotected under basic (97%) and acidic 
(quant) conditions respectively, and cyclization of the 36-membered ring, again using DMTMM as the 
coupling agent, delivered wewakazole 1 in 68% yield after 4 days at room temperature, at 0.55 mM 
concentration. The rotamerism observed in the acyclic intermediates was entirely absent in the macro-
cycle, and good NMR spectra could be obtained. A systematic 0.3 ppm difference in the 13C NMR spec-
trum not-withstanding, the NMR spectroscopic data obtained for this material matched closely those 
reported for the natural product allowing us to confirm the structure of wewakazole.  
 
Scheme 6. Synthesis of bis-oxazole fragment of wewakazole B. 
 
With wewakazole complete, attention turned to wewakazole B. Coupling of the octapeptide 3 with the 
bis-oxazole fragment 5 proceeded in 76% yield using DMTMM in chloroform. The C-terminal was 
deprotected first (85%), and then the Boc group was removed from the N-terminal using HCl in dioxane 
(quant). Cyclization was first attempted using the conditions reported by Wu et al.,4 with HATU in di-
chloromethane. After 7 days, the product could be isolated in 36% yield, with only a trace of tetra-
methylurea proving difficult to remove. An attempt to use PyBOP as the coupling agent, to circumvent 
the presence of the urea side-product, gave excellent conversion but purification was again very difficult 
due to the co-elution of wewakazole B with the tripyrrolidinophosphine oxide side product. As above, 
the best results were obtained using DMTMM in chloroform, which gave a 78% yield of clean material 
after five days at room temperature. The spectroscopic data obtained for synthetic wewakazole B 
matched the literature data for the natural product. 
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 Scheme 7. Completion of the synthesis of the wewakazoles. 
 
 
 
In summary, the total syntheses of wewakazole, and its congener wewakazole B have been carried out 
using rhodium catalyzed cycloadditions and N-H insertion reactions to provide the oxazoles. The overall 
strategy is both convergent and divergent in nature, and can readily be applied to the synthesis of ana-
logues of the natural products. 
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